Skip to main content

Articles

Page 5 of 60

  1. The study aimed to assess the usefulness of capillaroscopy and photoplethysmography in the search for early vascular anomalies in children with type 1 diabetes.

    Authors: Klaudia Bogusz-Górna, Adriana Polańska, Aleksandra Dańczak-Pazdrowska, Ryszard Żaba, Marta Sumińska, Piotr Fichna and Andrzej Kędzia
    Citation: Cardiovascular Diabetology 2023 22:285
  2. The Triglyceride-glucose (TyG) index, as a surrogate marker of insulin resistance, is independently associated with the severity of coronary artery lesions and the prognosis of coronary heart disease. The inve...

    Authors: Qiang Chen, Shiqiang Xiong, Zhen Zhang, Xiuqiong Yu, Yingzhong Chen, Tao Ye, Siqi Yang, Lingyao Qi, Xu Chen, Hanxiong Liu, Jingang Zheng and Lin Cai
    Citation: Cardiovascular Diabetology 2023 22:284
  3. It is unclear to what extent genetics explain the familial clustering and the co-occurrence of distinct cardiometabolic disorders in the general population. We therefore aimed to quantify the familial (co-)agg...

    Authors: Rima D. Triatin, Zekai Chen, Alireza Ani, Rujia Wang, Catharina A. Hartman, Ilja M. Nolte, Chris H. L. Thio and Harold Snieder
    Citation: Cardiovascular Diabetology 2023 22:282
  4. Among patients with acute coronary syndrome and percutaneous coronary intervention, stress hyperglycemia ratio (SHR) is primarily associated with short-term unfavorable outcomes. However, the relationship betw...

    Authors: Jin Liu, Yang Zhou, Haozhang Huang, Rui Liu, Yu Kang, Tingting Zhu, Jielan Wu, Yuwei Gao, Yuqi Li, Chenyang Wang, Shiqun Chen, Nianjin Xie, Xueyan Zheng, Ruilin Meng, Yong Liu, Ning Tan…
    Citation: Cardiovascular Diabetology 2023 22:281
  5. Diabetes mellitus (DM) accelerates the progression of aortic stenosis (AS), but how their underlying molecular mechanisms interact is not clear. Moreover, whether DM contributes to clinically relevant sex-diff...

    Authors: Ernesto Martín-Núñez, Miriam Goñi-Olóriz, Lara Matilla, Mattie Garaikoetxea, Laura Mourino-Alvarez, Adela Navarro, Amaya Fernández-Celis, Ibai Tamayo, Alicia Gainza, Virginia Álvarez, Rafael Sádaba, María G. Barderas, Eva Jover and Natalia López-Andrés
    Citation: Cardiovascular Diabetology 2023 22:280
  6. The association between the triglyceride-glucose (TyG) index and mortality in cardiovascular disease (CVD) patients with diabetes or pre-diabetes remains unclear. This study aimed to investigate the relationsh...

    Authors: Qin Zhang, Shucai Xiao, Xiaojuan Jiao and Yunfeng Shen
    Citation: Cardiovascular Diabetology 2023 22:279
  7. Sodium-glucose cotransporter 2 (SGLT2) inhibitors have shown promise in reducing the risk of atrial fibrillation (AF). However, the results are controversial and the underlying metabolic mechanism remains uncl...

    Authors: Jiang Li, Yuefeng Yu, Ying Sun, Bowei Yu, Xiao Tan, Bin Wang, Yingli Lu and Ningjian Wang
    Citation: Cardiovascular Diabetology 2023 22:278
  8. In recent years, several novel agents have become available to treat individuals with type 2 diabetes (T2D), such as sodium-glucose cotransporter-2 inhibitors (SGLT-2i), tirzepatide, which is a dual glucose-de...

    Authors: Antonio Ceriello, Helena W. Rodbard, Tadej Battelino, Frank Brosius, Francesco Cosentino, Jennifer Green, Linong Ji, Monika Kellerer, Susan Koob, Mikhail Kosiborod, Nebojsa Lalic, Nikolaus Marx, T. Prashant Nedungadi, Christopher G. Parkin, Lars Rydén, Wayne Huey-Herng Sheu…
    Citation: Cardiovascular Diabetology 2023 22:277
  9. O-GlcNAcylation is the enzymatic addition of a sugar, O-linked β-N-Acetylglucosamine, to the serine and threonine residues of proteins, and is abundant in diabetic conditions. We have previously shown that O-G...

    Authors: Chidinma A Okolo, Ei-Phyo Khaing, Valeria Mereacre, Rachel S Wallace, Michelle L Munro, Jeffrey R Erickson and Peter P. Jones
    Citation: Cardiovascular Diabetology 2023 22:276
  10. The stress hyperglycemia ratio (SHR) has demonstrated a noteworthy association with unfavorable cardiovascular clinical outcomes and heightened in-hospital mortality. Nonetheless, this relationship in critical...

    Authors: Le Li, Minghao Zhao, Zhuxin Zhang, Likun Zhou, Zhenhao Zhang, Yulong Xiong, Zhao Hu and Yan Yao
    Citation: Cardiovascular Diabetology 2023 22:275
  11. Evidence on the associations between baseline stromal cell-derived factor (SDF)-1 and clinical outcomes in acute ischemic stroke patients is lacking. The present study aimed to examine the relationship between...

    Authors: Shoujiang You, Hongyu Chen, Mengyuan Miao, Jigang Du, Bizhong Che, Tan Xu, Chun-Feng Liu, Yonghong Zhang, Jiang He, Xiaoyan Zhong, Yongjun Cao and Chongke Zhong
    Citation: Cardiovascular Diabetology 2023 22:274
  12. This study aimed to reveal the prevalence of sodium-glucose co-transporter 2 (SGLT2) inhibitor treatment and its association with restenosis risk in patients with diabetes mellitus undergoing endovascular ther...

    Authors: Mitsuyoshi Takahara, Yoshimitsu Soga, Masahiko Fujihara, Osamu Iida and Daizo Kawasaki
    Citation: Cardiovascular Diabetology 2023 22:273
  13. Effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1RAs) versus long-acting insulins (LAIs) on preventing progressive chronic kidney outcomes is uncertain for type 2 diabetes (T2D) patients requir...

    Authors: Zi-Yang Peng, Chun-Ting Yang, Wei-Hung Lin, Wen-Yu Yao, Huang-Tz Ou and Shihchen Kuo
    Citation: Cardiovascular Diabetology 2023 22:272
  14. There is mounting evidence that the Mediterranean diet prevents type 2 diabetes, but little is known about the role of Mediterranean lifestyles other than diet and among non-Mediterranean populations. This wor...

    Authors: Javier Maroto-Rodriguez, Rosario Ortolá, Adrián Carballo-Casla, Víctor Iriarte-Campo, Miguel Ángel Salinero-Fort, Fernando Rodríguez-Artalejo and Mercedes Sotos-Prieto
    Citation: Cardiovascular Diabetology 2023 22:271
  15. Previous studies have reported an association between a significant decline in estimated glomerular filtration rate (eGFR) over time and an increased risk of cardiovascular disease (CVD). This study aimed to i...

    Authors: Azra Ramezankhani, Fereidoun Azizi and Farzad Hadaegh
    Citation: Cardiovascular Diabetology 2023 22:270
  16. Pharmacological post-MI treatment is routinely initiated at intensive/cardiac care units. However, solid evidence for an early start of these therapies is only available for dual platelet therapy and statins, ...

    Authors: Dirk von Lewinski, Ewald Kolesnik, Faisal Aziz, Martin Benedikt, Norbert J. Tripolt, Markus Wallner, Peter N. Pferschy, Friederike von Lewinski, Nora Schwegel, Rury R. Holman, Abderrahim Oulhaj, Deddo Moertl, Jolanta Siller-Matula and Harald Sourij
    Citation: Cardiovascular Diabetology 2023 22:269
  17. Previous studies have reported that inflammatory responses can promote the onset of cardiovascular diseases; however, its association with cardiac conduction disorders remains unclear. The present community-ba...

    Authors: Lili Wu, Meimei Wu, Dandan Zhao, Shuohua Chen, Guodong Wang, Lina Xu, Yujing Wang, Lina An, Shouling Wu, Congliang Miao and Jiang Hong
    Citation: Cardiovascular Diabetology 2023 22:268
  18. Evidence regarding the neutrophil–lymphocyte ratio (NLR) and mortality risk in diabetes patients is scarce. This study investigated the relationship of the NLR with all-cause and cardiovascular mortality risk ...

    Authors: Gaiying Dong, Man Gan, Shilin Xu, Yanlin Xie, Ming Zhou and Liangliang Wu
    Citation: Cardiovascular Diabetology 2023 22:267
  19. The impact of Type 2 Diabetes (T2D) on the outcomes of heart transplantation (HT) has not yet been clearly established. The objectives of this study were to examine the trends in the prevalence of T2D among in...

    Authors: Ana Lopez-de-Andres, Rodrigo Jiménez-García, Valentin Hernández-Barrera, David Carabantes-Alarcon, Jose J. Zamorano-Leon, Ricardo Omaña Palanco, Jose L. del-Barrio, Javier de-Miguel-Díez, Jose M. de-Miguel-Yanes and Natividad Cuadrado-Corrales
    Citation: Cardiovascular Diabetology 2023 22:266
  20. Diabetes poses a significant threat to human health. There is a lack of large-scale cohort studies to explore the association between mortality risk and indicators beyond blood glucose monitoring in diabetic p...

    Authors: Fan Yang, Mingsi Wang, Yuzhu Chen, Jianjun Wu and Yilan Li
    Citation: Cardiovascular Diabetology 2023 22:265
  21. Frailty is an age-related geriatric syndrome that leads to a series of clinically negative events. A better understanding of the factors associated with frailty assists in preventing its progression. The trigl...

    Authors: Yin Yuan, Simiao Chen, Chunjin Lin, Xiaoming Huang, Siyang Lin, Feng Huang and Pengli Zhu
    Citation: Cardiovascular Diabetology 2023 22:264
  22. The impact of insulin resistance on the prognosis of heart failure with preserved ejection fraction (HFpEF) remains unknown. This study aimed to investigate the association between the triglyceride-glucose (Ty...

    Authors: Qing Zhou, Jie Yang, Hongyi Tang, Zexuan Guo, Wenyue Dong, Yiting Wang, Xiangbin Meng, Kuo Zhang, Wenyao Wang, Chunli Shao, Xinwei Hua and Yi-Da Tang
    Citation: Cardiovascular Diabetology 2023 22:263
  23. Several large observational prospective studies have reported a protection by the traditional Mediterranean diet against type 2 diabetes, but none of them used yearly repeated measures of dietary intake. Repea...

    Authors: Miguel A. Martínez-González, Pedro Montero, Miguel Ruiz-Canela, Estefanía Toledo, Ramón Estruch, Enrique Gómez-Gracia, Jun Li, Emilio Ros, Fernando Arós, Alvaro Hernáez, Dolores Corella, Miquel Fiol, José Lapetra, Lluis Serra-Majem, Xavier Pintó, Montse Cofán…
    Citation: Cardiovascular Diabetology 2023 22:262
  24. Patients with type 2 diabetes have an increased risk of death and cardiovascular events and people with diabetes or prediabetes have been found to have increased atherosclerotic burden in the coronary and caro...

    Authors: Carl Johan Östgren, Julia Otten, Karin Festin, Oskar Angerås, Göran Bergström, Kerstin Cederlund, Gunnar Engström, Maria J. Eriksson, Mats Eriksson, Tove Fall, Anders Gummesson, Emil Hagström, Urban Hellman, Stefan K. James, Tomas Jernberg, Johan Kihlberg…
    Citation: Cardiovascular Diabetology 2023 22:261
  25. Circulating MicroRNAs (miRNAs) carried by microvesicles (MVs) have various physiological and pathological functions by post-transcriptional regulation of gene expression being considered markers for many disea...

    Authors: Miruna Nemecz, Diana Simona Stefan, Ioana Karla Comarița, Alina Constantin, Gabriela Tanko, Cristian Guja and Adriana Georgescu
    Citation: Cardiovascular Diabetology 2023 22:260
  26. The relationship of cumulative remnant-cholesterol (Cum-RC) concentration with the risk of cardiovascular disease (CVD) in patients with hypertension remains unclear.

    Authors: Weiqiang Wu, Guanzhi Chen, Kuangyi Wu, Huancong Zheng, Yanjuan Chen, Xianxuan Wang, Zegui Huang, Zefeng Cai, Zhiwei Cai, Zhichao Chen, Yulong Lan, Shuohua Chen, Shouling Wu and Youren Chen
    Citation: Cardiovascular Diabetology 2023 22:258
  27. Diabetic peripheral neuropathy (DPN) has been shown to be independently associated with cardiovascular events and mortality. This study aimed to evaluate changes in left ventricular (LV) microvascular perfusio...

    Authors: Xue-Ming Li, Rui Shi, Meng-Ting Shen, Wei-Feng Yan, Li Jiang, Chen-Yan Min, Xiao-Jing Liu, Ying-Kun Guo and Zhi-Gang Yang
    Citation: Cardiovascular Diabetology 2023 22:256
  28. The Atherogenic Index of Plasma (AIP) is a newly identified biomarker associated with lipid metabolism, demonstrating significant prognostic capabilities in individuals diagnosed with cardiovascular disease. H...

    Authors: Jiasuer Alifu, Lanqing Xiang, Wen Zhang, Penglong Qi, Huiying Chen, Lu Liu, Guoqing Yin, Abdul-Quddus Mohammed, Xian Lv, Tingting Shi, Fuad A. Abdu and Wenliang Che
    Citation: Cardiovascular Diabetology 2023 22:255
  29. Stroke was reported to be highly correlated with the triglyceride glucose-body mass index (TyG-BMI). Nevertheless, literature exploring the association between changes in the TyG-BMI and stroke incidence is sc...

    Authors: Rong-Rui Huo, Lu Zhai, Qian Liao and Xue-Mei You
    Citation: Cardiovascular Diabetology 2023 22:254
  30. Whether recent reductions in cardiovascular disease (CVD) events and mortality in type 2 diabetes apply equally to both sexes is largely unknown. The aim of this study was to characterize temporal changes in C...

    Authors: Wendy A. Davis and Timothy M. E. Davis
    Citation: Cardiovascular Diabetology 2023 22:253
  31. A healthy lifestyle (HL) has been inversely related to type 2 diabetes (T2D) and cardiovascular disease (CVD). However, few studies have identified a metabolite profile associated with HL. The present study ai...

    Authors: Santiago Rios, Jesús F. García-Gavilán, Nancy Babio, Indira Paz-Graniel, Miguel Ruiz-Canela, Liming Liang, Clary B Clish, Estefania Toledo, Dolores Corella, Ramón Estruch, Emilio Ros, Montserrat Fitó, Fernando Arós, Miquel Fiol, Marta Guasch-Ferré, José M Santos-Lozano…
    Citation: Cardiovascular Diabetology 2023 22:252
  32. Insulin resistance (IR) is a pathophysiologic hallmark of type 2 diabetes and associated with the presence of chronic kidney disease (CKD). Experimental studies suggest that endothelin-1 increases IR. We asses...

    Authors: J. David Smeijer, Donald E. Kohan, Peter Rossing, Ricardo Correa-Rotter, Adrian Liew, Sydney C.W. Tang, Dick de Zeeuw, Ron T. Gansevoort, Wenjun Ju and Hiddo J. Lambers Heerspink
    Citation: Cardiovascular Diabetology 2023 22:251
  33. Authors: You Zhou, Chi Wang, Hebin Che, Liting Cheng, Di Zhu, Chongyou Rao, Qin Zhong, Zongren Li, Xiao Wang, Zisheng Wu and Kunlun He
    Citation: Cardiovascular Diabetology 2023 22:250

    The original article was published in Cardiovascular Diabetology 2023 22:171

  34. Circulating biomarkers of metabolic and cardiovascular diseases can help in the early detection and prevention of those diseases. Using proton nuclear magnetic resonance (1H-NMR), we aimed to study the plasma ...

    Authors: Juan Moreno-Vedia, Dídac Llop, Ricardo Rodríguez-Calvo, Núria Plana, Núria Amigó, Roser Rosales, Yaiza Esteban, Josefa Girona, Lluís Masana and Daiana Ibarretxe
    Citation: Cardiovascular Diabetology 2023 22:249
  35. Type 2 diabetes mellitus (T2DM) is a major global health issue and a significant risk factor for atherosclerosis. Atherosclerosis in T2DM patients has been associated with inflammation, insulin resistance, hyp...

    Authors: Louise Ménégaut, Aline Laubriet, Valentin Crespy, Damien Leleu, Thomas Pilot, Kevin Van Dongen, Jean-Paul Pais de Barros, Thomas Gautier, Jean-Michel Petit, Charles Thomas, Maxime Nguyen, Eric Steinmetz and David Masson
    Citation: Cardiovascular Diabetology 2023 22:248
  36. MicroRNAs (miRNAs) play a crucial role in regulating adaptive and maladaptive responses in cardiovascular diseases, making them attractive targets for potential biomarkers. However, their potential as novel bi...

    Authors: Mehrdad Samadishadlou, Reza Rahbarghazi, Zeynab Piryaei, Mahdad Esmaeili, Çığır Biray Avcı, Farhad Bani and Kaveh Kavousi
    Citation: Cardiovascular Diabetology 2023 22:247
  37. Diabetes mellitus (DM) is associated with thrombogenicity, clinically manifested with atherothrombotic events after percutaneous cutaneous intervention (PCI). This study aimed to investigate association betwee...

    Authors: Ki-Hyun Jeon, Young-Hoon Jeong, In-Ho Chae, Byeong-Keuk Kim, Hyung Joon Joo, Kiyuk Chang, Yongwhi Park, Young Bin Song, Sung Gyun Ahn, Sang Yeub Lee, Jung Rae Cho, Ae-Young Her, Hyo-Soo Kim, Moo Hyun Kim, Do-Sun Lim, Eun-Seok Shin…
    Citation: Cardiovascular Diabetology 2023 22:245
  38. Insulin resistance (IR) is a major metabolic disorder observed in heart failure (HF) and is tightly associated with patients’ poor prognosis. The triglyceride-glucose index (TyG) has been proposed as a surroga...

    Authors: Amirmohammad Khalaji, Amir Hossein Behnoush, Shaghayegh Khanmohammadi, Kimiya Ghanbari Mardasi, Sourena Sharifkashani, Amirhossein Sahebkar, Caterina Vinciguerra and Alessandro Cannavo
    Citation: Cardiovascular Diabetology 2023 22:244
  39. Endogenous estrogen is cardio-protective in healthy premenopausal women. Despite this favorable action of estrogen, animal models depict a detrimental effect of estradiol on vascular function in the presence o...

    Authors: Abigayle B. Simon, Cassandra C. Derella, Marsha Blackburn, Jeffrey Thomas, Lawrence C. Layman, Matthew S. Nicholson, Jennifer Waller, Ahmed Elmarakby, Karim M. Saad and Ryan A. Harris
    Citation: Cardiovascular Diabetology 2023 22:243
  40. To assess how inaccurately the body mass index (BMI) is used to diagnose obesity compared to body fat percentage (BF%) measurement and to compare the cardiometabolic risk in children and adolescents with or wi...

    Authors: J. Karina Zapata, M. Cristina Azcona-Sanjulian, Victoria Catalán, Beatriz Ramírez, Camilo Silva, Amaia Rodríguez, Javier Escalada, Gema Frühbeck and Javier Gómez-Ambrosi
    Citation: Cardiovascular Diabetology 2023 22:240
  41. High triglyceride-glucose index (TyG) is a major risk factor for heart failure, but the long-term effect of high TyG index on the risk of developing heart failure remains unclear. Therefore, we aimed to determ...

    Authors: Huancong Zheng, Guanzhi Chen, Kuangyi Wu, Weiqiang Wu, Zegui Huang, Xianxuan Wang, Zekai Chen, Zefeng Cai, Zhiwei Cai, Yulong Lan, Shouling Wu and Youren Chen
    Citation: Cardiovascular Diabetology 2023 22:239
  42. The triglyceride-glucose (TyG) index is a reliable surrogate marker of insulin resistance (IR). However, whether the TyG index has prognostic value in patients with moderate to severe aortic stenosis (AS) rema...

    Authors: Rihua Huang, Xinghao Xu, Chaoguang Xu, Shaozhao Zhang, Zhenyu Xiong, Menghui Liu, Yiquan Huang, Han Wen, Yue Guo, Xinxue Liao and Xiaodong Zhuang
    Citation: Cardiovascular Diabetology 2023 22:238
  43. Diabetes mellitus is a metabolic disease characterized by long-term hyperglycaemia, which leads to microangiopathy and macroangiopathy and ultimately increases the mortality of diabetic patients. Endothelial d...

    Authors: Ying An, Bu-tuo Xu, Sheng-rong Wan, Xiu-mei Ma, Yang Long, Yong Xu and Zong-zhe Jiang
    Citation: Cardiovascular Diabetology 2023 22:237
  44. The presence of type 1 diabetes mellitus (T1DM) has been demonstrated to pose an increased risk for developing cardiovascular diseases (CVDs). However, the causal relationships between T1DM and CVDs remain unc...

    Authors: Zirui Liu, Haocheng Wang, Zhengkai Yang, Yu Lu and Cao Zou
    Citation: Cardiovascular Diabetology 2023 22:236
  45. Randomized controlled trials (RCTs) reported contrasting results about reverse left ventricular remodeling (LVR) after sodium-glucose co-transporter-2 inhibitors (SGLT2i) therapy in patients with heart failure...

    Authors: Erberto Carluccio, Paolo Biagioli, Gianpaolo Reboldi, Anna Mengoni, Rosanna Lauciello, Cinzia Zuchi, Sandra D’Addario, Giuliana Bardelli and Giuseppe Ambrosio
    Citation: Cardiovascular Diabetology 2023 22:235

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    2,523,778 downloads
    3,115 Altmetric mentions